Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient's Outcome in Severe Traumatic Brain Injury

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2017 Feb 18

PMID 28208906

Citations 4

Authors

Masoud Hatefi

Masoud Moghadas Dastjerdi

Bahareh Ghiasi

Asghar Rahmani

Affiliations

Soon will be listed here.

Abstract

Introduction: The prognostic value of serum Uric Acid (UA) levels in Traumatic Brain Injury (TBI) is unclear.

Aim: To investigate the relationship between serum UA levels and prognosis of patients with TBI when in hospital and at six months after discharge.

Materials And Methods: All patients attended our emergency department during July 2014 and December 2015 and were consecutively entered into the study and among 890 evaluated candidates based on inclusion criteria we finally investigated the serum UA levels of 725 TBI patients. Computed Tomography (CT) images of the brain were obtained within the first 24 hours of hospitalization. Outcome was assessed using the Glasgow Outcome Scale (GOS) score at discharge and at six months after discharge.

Results: Data of 725 patients (42.89% men; mean age: 54.69±12.37 years) were analyzed. Mean±Standard Deviation (SD) of Glasgow Coma Scale (GCS) scores was 4.65±1.76. Serum levels of UA, when in hospital and at six months after discharge, among those who died were lower than those who survived (in hospital: 0.126±0.026 vs. 0.243±0.942 mmol/l, p = 0.000; 6 months post-discharge: 0.130±0.044 vs. 0.286±0.069 mmol/l, p<0.001). The mean UA plasma was significantly different between deceased and alive patients according to GOS scores (p<0.001 and p=0.030, respectively). The UA levels showed a significant relationship with GCS scores and severity of brain injury assessed using the Marshall Classification Score (p=0.005).

Conclusion: Our results showed a strong relationship between UA levels and patients' outcomes either in hospital or at six months after discharge. Serum UA level could be considered as a valuable marker for evaluating the severity of brain injury and outcomes of TBI.

Citing Articles

Decreased serum uric acid in patients with traumatic brain injury or after cerebral tumor surgery.

He M, Zheng J, Liu H, Wu Y, Xue X, Wu C Neurosciences (Riyadh). 2021; 26(1):36-44.

PMID: 33530042 PMC: 8015494. DOI: 10.17712/nsj.2021.1.20200089.

Uric acid released from poly(ε-caprolactone) fibers as a treatment platform for spinal cord injury.

Singh N, Khaliq S, Patel M, Wheeler N, Vedula S, Freeman J J Tissue Eng Regen Med. 2020; 15(1):14-23.

PMID: 33175472 PMC: 7864535. DOI: 10.1002/term.3153.

The Predictive Value of Serum Uric Acid on Acute Kidney Injury following Traumatic Brain Injury.

Wang R, He M, Ou X, Xie X, Kang Y Biomed Res Int. 2020; 2020:2874369.

PMID: 32934958 PMC: 7479452. DOI: 10.1155/2020/2874369.

Cypin: A novel target for traumatic brain injury.

Swiatkowski P, Sewell E, Sweet E, Dickson S, Swanson R, McEwan S Neurobiol Dis. 2018; 119:13-25.

PMID: 30031156 PMC: 6214165. DOI: 10.1016/j.nbd.2018.07.019.

References

Shen C, Guo Y, Luo W, Lin C, Ding M . Serum urate and the risk of Parkinson's disease: results from a meta-analysis. Can J Neurol Sci. 2012; 40(1):73-9. DOI: 10.1017/s0317167100012981. View

Romanos E, Planas A, Amaro S, Chamorro A . Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab. 2006; 27(1):14-20. DOI: 10.1038/sj.jcbfm.9600312. View

Choi S, Clifton G, Marmarou A, Miller E . Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma. J Neurotrauma. 2002; 19(1):17-22. DOI: 10.1089/089771502753460204. View

Szabo C, Ischiropoulos H, Radi R . Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007; 6(8):662-80. DOI: 10.1038/nrd2222. View

Keller J, Kindy M, Holtsberg F, St Clair D, Yen H, Germeyer A . Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci. 1998; 18(2):687-97. PMC: 6792529. View

Bowman G, Shannon J, Frei B, Kaye J, Quinn J . Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010; 19(4):1331-6. PMC: 2859185. DOI: 10.3233/JAD-2010-1330. View

Gao X, Qi L, Qiao N, Choi H, Curhan G, Tucker K . Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension. 2007; 50(2):306-12. DOI: 10.1161/HYPERTENSIONAHA.107.091041. View

Amaro S, Chamorro A . Translational stroke research of the combination of thrombolysis and antioxidant therapy. Stroke. 2011; 42(5):1495-9. DOI: 10.1161/STROKEAHA.111.615039. View

Ames B, Cathcart R, Schwiers E, Hochstein P . Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981; 78(11):6858-62. PMC: 349151. DOI: 10.1073/pnas.78.11.6858. View

10.

Miller A, Drummond G, Sobey C . Reactive oxygen species in the cerebral circulation: are they all bad?. Antioxid Redox Signal. 2006; 8(7-8):1113-20. DOI: 10.1089/ars.2006.8.1113. View

11.

Moreira P, Honda K, Zhu X, Nunomura A, Casadesus G, Smith M . Brain and brawn: parallels in oxidative strength. Neurology. 2006; 66(2 Suppl 1):S97-101. DOI: 10.1212/01.wnl.0000192307.15103.83. View

12.

Choi H, Liu S, Curhan G . Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005; 52(1):283-9. DOI: 10.1002/art.20761. View

13.

M C Gutteridge J, Halliwell B . Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun. 2010; 393(4):561-4. DOI: 10.1016/j.bbrc.2010.02.071. View

14.

Davies K, Sevanian A, Hochstein P . Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986; 235(3):747-54. PMC: 1146751. DOI: 10.1042/bj2350747. View

15.

Schwarzschild M, Schwid S, Marek K, Watts A, Lang A, Oakes D . Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol. 2008; 65(6):716-23. PMC: 2574855. DOI: 10.1001/archneur.2008.65.6.nct70003. View

16.

Eliasson M, Huang Z, Ferrante R, Sasamata M, Molliver M, Snyder S . Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J Neurosci. 1999; 19(14):5910-8. PMC: 6783066. View

17.

Jenner P . Oxidative stress in Parkinson's disease. Ann Neurol. 2003; 53 Suppl 3:S26-36; discussion S36-8. DOI: 10.1002/ana.10483. View

18.

Selim M, Ratan R . The role of iron neurotoxicity in ischemic stroke. Ageing Res Rev. 2004; 3(3):345-53. DOI: 10.1016/j.arr.2004.04.001. View

19.

Toncev G, Milicic B, Toncev S, Samardzic G . Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction. Eur J Neurol. 2002; 9(3):221-6. DOI: 10.1046/j.1468-1331.2002.00384.x. View

20.

Guo Q, Sebastian L, Sopher B, Miller M, Ware C, Martin G . Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J Neurochem. 1999; 72(3):1019-29. DOI: 10.1046/j.1471-4159.1999.0721019.x. View